Literature DB >> 8221556

Combined cystic teratoma and hepatoblastoma of the liver. Probable divergent differentiation of an uncommitted hepatic precursor cell.

R J Conrad1, D Gribbin, N I Walker, T H Ong.   

Abstract

BACKGROUND: Hepatic cystic teratoma is an extremely rare tumor and hepatoblastoma a relatively rare tumor of childhood. Their occurrence as a combined tumor has not been previously reported.
METHODS: The relevant clinical, radiologic, and pathologic findings are presented.
RESULTS: A 17-month-old boy presented with an abdominal mass. Imaging studies suggested an intrahepatic teratoma, but serum alpha-fetoprotein levels were extremely elevated. The resected tumor comprised adjoining benign cystic teratoma and epithelial hepatoblastoma. The child remains alive and well 37 months after complete resection of the tumor.
CONCLUSIONS: The tumor was considered most likely to originate from divergent differentiation of a single uncommitted liver precursor cell.

Entities:  

Mesh:

Year:  1993        PMID: 8221556     DOI: 10.1002/1097-0142(19931115)72:10<2910::aid-cncr2820721009>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Huge immature teratoma of the liver in an adult: a case report and review of the literature.

Authors:  Seyed Ali Malek-Hosseini; Saeed Reza Baezzat; Alireza Shamsaie; Bita Geramizadeh; Roohollah Salahi; Heshmatollah Salahi; Mehrzad Lotfi
Journal:  Clin J Gastroenterol       Date:  2010-10-30

2.  Small epithelial cells and the histogenesis of hepatoblastoma. Electron microscopic, immunoelectron microscopic, and immunohistochemical findings.

Authors:  P Ruck; J C Xiao; E Kaiserling
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

3.  Resection of a mature cystic teratoma of the liver harboring a carcinoid tumor.

Authors:  Alexei A Krainev; Viney K Mathavan; Daniel Klink; Rocio C Fuentes; Ruemu Birhiray
Journal:  J Surg Case Rep       Date:  2018-10-31

4.  Efficacy analysis of C5V chemotherapy combined with transcatheter subcutaneous radiofrequency ablation in the treatment of children with advanced (Stage III/IV) hepatoblastoma.

Authors:  Yan-Wei Qi; Wei-Dong Liu; Lei Gao; Ying-Xin Gong
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

5.  Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge.

Authors:  Alexander Moll; Alexander Krenauer; Uta Bierbach; Holger Till; Wolfgang Hirsch; Ivo Leuschner; Nicole Schmitz; Christian Wittekind; Thomas Aigner
Journal:  Diagn Pathol       Date:  2009-11-12       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.